ARCHIVES

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

This article is from The Cancer Letter archive.

Vol. 19 No. 39 | October 8, 1993

Download PDF Visit The Full Archive

Related Articles

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

NCI-Approved Clinical Trials

April 29, 2005

FDA Committee to Discuss Policy On Combinations

January 7, 1977